PYPD logo

PolyPid Ltd.

PYPD
Healthcare|Biotechnology|IL
$6.14
+0.47 (+8.29%)
DCF Value
$0.12
Tangible Book / Share
$0.24
Cash / Share
$0.29
Next Earnings Report
Nov 11, 2026
EPS est. $0.46 · Revenue est. $30.0M
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Nov 26, 2025 (424B5). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

PolyPid to Report Third Quarter 2026 Financial Results and Operational Highlights on November 11, 2026
Oct 29, 2026 · GlobeNewsWire
PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix™ Based Product Candidate for the Treatment of Diabetic Foot Infections
Oct 28, 2026 · GlobeNewsWire
PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026
Oct 21, 2026 · GlobeNewsWire
PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026
Oct 15, 2026 · GlobeNewsWire
European Medicines Agency Validates PolyPid's Marketing Authorization Application for D-PLEX₁₀₀
Oct 1, 2026 · GlobeNewsWire
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
Oct 1, 2026 · GlobeNewsWire
PolyPid Announces Participation in Upcoming Fall Investor Conferences
Sep 15, 2026 · GlobeNewsWire
PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Aug 12, 2026 · GlobeNewsWire

SEC Filings (66)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 28, 20266-KForeign issuer reportDocumentIndex
Oct 1, 20266-KForeign issuer reportDocumentIndex
Oct 1, 20266-KForeign issuer reportDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 20266-KForeign issuer reportDocumentIndex
Aug 12, 2026S-8Employee stock planDocumentIndex
Aug 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 20266-KForeign issuer reportDocumentIndex
Jul 29, 20266-KForeign issuer reportDocumentIndex
Jul 21, 20266-KForeign issuer reportDocumentIndex
Jul 15, 20266-KForeign issuer reportDocumentIndex
Jun 10, 20266-KForeign issuer reportDocumentIndex
Jun 1, 20266-KForeign issuer reportDocumentIndex
May 13, 20266-KForeign issuer reportDocumentIndex
May 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 4, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 31, 20266-KForeign issuer reportDocumentIndex
Feb 25, 202620-FAnnual report (foreign)DocumentIndex
Feb 11, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 11, 20266-KForeign issuer reportDocumentIndex
Feb 4, 20266-KForeign issuer reportDocumentIndex
Jan 30, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Dec 31, 20256-KForeign issuer reportDocumentIndex
Dec 16, 20256-KForeign issuer reportDocumentIndex
Dec 3, 20256-KForeign issuer reportDocumentIndex
Nov 26, 2025424B5Offering prospectusDocumentIndex
Nov 26, 20256-KForeign issuer reportDocumentIndex
Nov 12, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 12, 20256-KForeign issuer reportDocumentIndex
Sep 16, 20256-KForeign issuer reportDocumentIndex
Sep 8, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 20256-KForeign issuer reportDocumentIndex
Aug 13, 2025S-8Employee stock planDocumentIndex
Aug 13, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 20256-KForeign issuer reportDocumentIndex
Aug 12, 20256-KForeign issuer reportDocumentIndex
Aug 6, 2025EFFECTDocumentIndex
Jul 29, 2025SC 13GPassive 5%+ stakeDocumentIndex
Jul 29, 2025F-3Shelf registrationDocumentIndex
Jul 15, 20256-KForeign issuer reportDocumentIndex